Concepedia

Małgorzata Wach

MW

6

Publications

250

Citations

6

H-Index

2002

Active since

Affiliations

Medical University of Lublin(Current)

Gdańsk Medical University

Jagiellonian University

Medical University of Silesia

Wroclaw Medical University

Małgorzata Wach is an author at Medical University of Lublin specializing in medicine, cancer research, and oncology.

Top concepts

Publications per year

2002–2022

6

Publications

6

Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

Paolo Ghia, Andrzej Pluta, Małgorzata Wach et al. · HemaSphere · 2022 · 95 citations · Full text

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

Jarosław Czyż, Rafał Dziadziuszko, W. Knopińska-Postuszuy et al. · Annals of Oncology · 2004 · 55 citations · Full text

, , +10

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

Agata Wrzesień‐Kuś, Tadeusz Robak, Agnieszka Wierzbowska et al. · Annals of Hematology · 2005 · 42 citations

, , +11

Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study

Paolo Ghia, Andrzej Pluta, Małgorzata Wach et al. · Hematological Oncology · 2019 · 26 citations

, , +20

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group

Jarosław Czyż, Andrzej Hellmann, Rafał Dziadziuszko et al. · Bone Marrow Transplantation · 2002 · 22 citations · Full text

, , +14

Rows per page

1–5 of 6